Bay Street News, May 14th, 2024

CAMBRIDGE, Massachusetts and TORONTO, Ontario, May 14, 2024 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company […]

TUS+VEN+HMA Triplet Protocol in 1L Therapy for Newly Diagnosed AML was Submitted to the FDA During Q1 and is Now […]

– Reports Record Projected Revenue Backlog of $210 million more than doubling following the acquisition of Rhode Island Radiation Therapy […]

Completed dosing in cohort one (low dose, 5.7×1014total vg) of REVEAL Phase 1/2 adolescent and adult trial with longer-term data […]

On track for regulatory filing for First-in-Human (FIH) study of KRRO-110 in patients with Alpha-1 Antitrypsin Deficiency (AATD) anticipated in […]

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a […]

Q1 revenue of $19.7 million, increasing 51% year-over-year Q1 gross profit increased 64% year-over-year to $12.2 million with a gross margin […]

EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a […]

VANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) — MAG Silver Corp. (TSX / NYSE American: MAG) (“MAG”, or the […]

NOT FOR DISTRIBUTION IN THE UNITED STATES.FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES […]